House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Cardiology · CSI

Coronary angiography with renal dysfunction

CSI
B
Source:CSI Practice Guidelines for Angiography in Patients with Renal Dysfunction (2020)KDIGO 2024 CKD Clinical Practice Guideline (CIN/CA-AKI definitions)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • eGFR <30 mL/min/1.73 m² with planned coronary angiography — high CA-AKI risk; strongly consider alternative diagnostics or carefully limit contrast volume[1]
  • Acute kidney injury within 48 h of contrast (creatinine rise ≥0.3 mg/dL or ≥50% baseline) — CA-AKI; pause nephrotoxins and reassess[2]
  • Diabetes plus eGFR <60 — additive CA-AKI risk; mandatory hydration protocol and minimum-volume contrast[1]
  • Decompensated heart failure with planned angiography — IV hydration may worsen pulmonary oedema; balance with diuresis under monitoring[1]

First-line treatment

Interventions

  • Peri-procedural isotonic IV hydration[1]
    0.9% saline 1 mL/kg/h for 6–12 h pre- and 6–12 h post-procedure (reduce in HF). Single most effective preventive measure
  • Minimum-volume low-osmolar or iso-osmolar contrast[1]
    Limit contrast to <30 mL or <3× eGFR; iso-osmolar agents (iodixanol) preferred in eGFR <30; low-osmolar agents acceptable in eGFR 30–60
  • Pause nephrotoxic medications[2]
    Hold NSAIDs, aminoglycosides, and metformin (where eGFR <30) on the day of contrast and for 48 h post; do NOT routinely stop ACEi/ARB or SGLT2 inhibitors

First-line drug therapy

DrugClassAdultPaediatricNotes
N-acetylcysteine (oral)[1]Antioxidant prophylaxis600–1200 mg PO BD on day before and day of procedure (4 doses total)—Optional adjunct; KDIGO permits with hydration despite mixed evidence; low cost and minimal harm
Sodium bicarbonate (alternative hydration)[1]Isotonic alkalinising fluid150 mEq sodium bicarbonate in 1 L D5W; 3 mL/kg/h × 1 h pre, then 1 mL/kg/h × 6 h post—Equivalent to saline in major trials; choose by local availability; do not combine with saline
N-acetylcysteine (oral)[1]
Antioxidant prophylaxis
Adult
600–1200 mg PO BD on day before and day of procedure (4 doses total)
Paediatric
—
Optional adjunct; KDIGO permits with hydration despite mixed evidence; low cost and minimal harm
Sodium bicarbonate (alternative hydration)[1]
Isotonic alkalinising fluid
Adult
150 mEq sodium bicarbonate in 1 L D5W; 3 mL/kg/h × 1 h pre, then 1 mL/kg/h × 6 h post
Paediatric
—
Equivalent to saline in major trials; choose by local availability; do not combine with saline

Safety-net

  1. Drink fluids freely on the day before and day after the angiogram unless told otherwise — staying well hydrated protects the kidneys[1]
  2. Pause ibuprofen and other anti-inflammatories for at least 48 hours before and after — they raise the risk of contrast-induced kidney injury[2]
  3. Hold metformin on the day of the procedure if your eGFR is <30; restart 48 hours after, only if a follow-up creatinine confirms stable kidney function[2]

Referral criteria

  • eGFR <30 with planned non-emergent coronary angiographyNephrology and interventional cardiology shared decision making; consider stress imaging or coronary CTA as alternative[1]
  • Post-procedural CA-AKI with creatinine rise persisting at 7 daysNephrology[2]
  • Acute pulmonary oedema during peri-procedural hydrationCardiology and emergency department; cease hydration, give IV diuretic[1]

Clinical summary

Pre- and peri-procedural strategies to prevent contrast-associated AKI in patients with chronic kidney disease undergoing coronary angiography or PCI.

References

  1. 1.CSI Practice Guidelines for Angiography in Patients with Renal Dysfunction; KDIGO 2024 CKD Clinical Practice Guideline (CIN/CA-AKI definitions) (2020)
  2. 2.KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International (2024)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References